VIC DRUG ALERT JUNE 2022
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect
Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors | SpringerLink
Opioids in cancer: The κ‑opioid receptor (Review)
Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents | PNAS
Ketamine acts like an opioid, Stanford study suggests
Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective - Hashimoto - 2019 - Psychiatry and Clinical Neurosciences - Wiley Online Library
Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience
Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders? | Neuropsychopharmacology
Use of Ketamine in Hospitalized Patients - The Hospitalist
Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors | SpringerLink
Frontiers | Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant
Top: Distribution of kappa opioid (7-transmembrane receptor), estrogen,... | Download Scientific Diagram
Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression | Scientific Reports
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Contribution of the opioid system to depression and to the therapeutic effects of classical antidepressants and ketamine - ScienceDirect
κ-opioid receptor - Wikipedia
Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience
Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience
Ketamine: A tale of two enantiomers - Luke A Jelen, Allan H Young, James M Stone, 2021
Frontiers | Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders
Contribution of the opioid system to depression and to the therapeutic effects of classical antidepressants and ketamine - ScienceDirect
Biomolecules | Free Full-Text | Ketamine Improves Desensitization of µ-Opioid Receptors Induced by Repeated Treatment with Fentanyl but Not with Morphine
Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System
Ketamine: A tale of two enantiomers - Luke A Jelen, Allan H Young, James M Stone, 2021
